Singapore Health Sciences Authority: Four reports of 'non-serious adverse events' in over 2,000 doses of Nuvaxovid Covid-19 vaccine administered

… long-established protein-based technology that is an alternative … Nuvaxovid Covid-19 vaccine in Singapore, the Health Sciences Authority … long-established protein-based technology that is an alternative … the risks in the Singapore context,” HSA added. …